Table of Content
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Middle East and Africa Human Vaccines Market, by Technology
5.1 Introduction
5.1.1 Attenuated
5.1.2 Inactivated
5.1.3 Toxoid
5.1.4 Conjugate and Subunit
5.1.5 Recombinant DNA
6 Middle East and Africa Human Vaccines Market, by Disease Indication
6.1 Introduction
6.1.1 Pneumococcal
6.1.2 Influenza
6.1.3 Hepatitis
6.1.4 Rotavirus
6.1.5 DTP
6.1.6 Polio
6.1.7 Others
7 Middle East and Africa Human Vaccines Market, by Type
7.1 Introduction
7.1.1 Prophylactic
7.1.2 Therapeutic
8 Middle East and Africa Human Vaccines Market, by Composition
8.1 Introduction
8.1.1 Mono vaccine and
8.1.2 Combination vaccines
9 Middle East and Africa Human Vaccines Market, by Route of Administration
9.1 Introduction
9.1.1 Oral
9.1.2 Injectible
9.1.3 Others
10 Middle East and Africa Human Vaccines Market, by End User
10.1 Introduction
10.1.1 Children
10.1.2 Adults
11 Middle East and Africa Human Vaccines Market, by Country
11.1 Introduction
11.1.2 UAE
11. 1.3 Egypt
11. 1.4 Saudi Arabia
11. 1.5 Kuwait
11. 1.6 Qatar
11. 1.7 Oman
12 Company Landscape
12.1 Introduction
12.1.1 Mergers Acquisitions
12.1.2 Collaborations
12.1.3 Release/New Product Launches
12.1.4 Other (Expansion, Updates, Partnership)
13 Company Profile
13.1 GlaxoSmithKline Plc.
13.1.1 Company Overview
13.1.2 Product/Business Segment Overview
13.1.3 Financials
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Merck & Co. Inc.
13.2.1 Overview
13.2.2 Product/Business Segment Overview
13.2.3 Financials
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Pfizer, Inc.
13.3.1 Overview
13.3.2 Product/Business Segment Overview
13.3.3 Financials
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.4 Sanofi Pasteur, Inc.
13.4.1 Overview
13.4.2 Product/Business Segment Overview
13.4.3 Financials
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.5 AstraZeneca Plc.
13.5.1 Overview
13.5.2 Product/Business Segment Overview
13.5.3 Financials
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 Bharat Biotech
13.6.1 Overview
13.6.2 Product/Business Segment Overview
13.6.3 Financials
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 Shenzhen Kangtai Biological Products
13.7.1 Overview
13.7.2 Product/Business Segment Overview
13.7.3 Financials
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 Valeant Pharmaceuticals
13.8.1 Overview
13.8.2 Product/Business Segment Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 Emergent Biosolutions Inc.
13.9.1 Overview
13.9.2 Product/Business Segment Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 Astellas Pharma Inc.
13.10.1 Overview
13.10.2 Product/Business Segment Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Panacea Biotec
13.11.1 Overview
13.11.2 Product/Business Segment Overview
13.11.3 Financials
13.11.4 Key Developments
13.11.5 SWOT Analysis
14 Others
15 Appendix
List of Tables
TABLE 1 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, 2023-2030 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY COMPOSITION, 2023-2030 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY REGION, 2023-2030 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY TECHNOLOGY
FIGURE 4 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY DISEASE INDICATION
FIGURE 5 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY TYPE
FIGURE 6 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY COMPOSITION
FIGURE 7 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 8 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY END USER
FIGURE 9 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET, BY REGION
FIGURE 10 MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
